Anna Kalff
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Oncology top 10%
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
Papers in
- Hematology 40
- Multiple Myeloma Research and Treatments 36
- Hematopoietic Stem Cell Transplantation 6
-
- Protein Degradation and Inhibitors 13
- Cancer therapeutics and mechanisms 5
- Histone Deacetylase Inhibitors Research 5
- Co-authors
- Andrew Spencer (38 shared papers)Tiffany Khong (17 shared papers)Sridurga Mithraprabhu (11 shared papers)Annie Chow (1 shared paper)Andrew Grigg (2 shared papers)Jane S. Hocking (6 shared papers)Hang Quach (10 shared papers)Krystal Bergin (14 shared papers)
- Journals
- Blood (12 papers)British Journal of Haematology (6 papers)Bone Marrow Transplantation (3 papers)Leukemia (2 papers)Haematologica (2 papers)
- Partner nations
- AustraliaUnited StatesNew Zealand
In The Last Decade
Anna Kalff
42 papers receiving 653 citations
Peers
Comparison fields: 5 of 53
- Hematology 477
- Oncology 238
- Cancer Research 120
- Genetics 77
- Molecular Biology 436
Countries citing papers authored by Anna Kalff
This map shows the geographic impact of Anna Kalff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Kalff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Kalff more than expected).
Fields of papers citing papers by Anna Kalff
This network shows the impact of papers produced by Anna Kalff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Kalff. The network helps show where Anna Kalff may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Kalff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 144 | |
| 2 | 2012 | 84 | |
| 3 | 2016 | 80 | |
| 4 | 2020 | 51 | |
| 5 | 2019 | 46 | |
| 6 | 2010 | 45 | |
| 7 | 2016 | 30 | |
| 8 | 2013 | 30 | |
| 9 | 2012 | 24 | |
| 10 | 2019 | 13 | |
| 11 | 2018 | 12 | |
| 12 | 2013 | 10 | |
| 13 | 2019 | 9 | |
| 14 | 2018 | 7 | |
| 15 | 2007 | 7 | |
| 16 | 2023 | 6 | |
| 17 | 2021 | 6 | |
| 18 | 2020 | 6 | |
| 19 | 2014 | 4 | |
| 20 | 2017 | 4 |
About Anna Kalff
Anna Kalff is a scholar working on Hematology, Molecular Biology, Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 46 papers that have together received 661 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (36 papers), Protein Degradation and Inhibitors (13 papers), Peptidase Inhibition and Analysis (10 papers), Cancer Treatment and Pharmacology (7 papers), Hematopoietic Stem Cell Transplantation (6 papers), Cancer therapeutics and mechanisms (5 papers), Cancer Genomics and Diagnostics (5 papers) and Histone Deacetylase Inhibitors Research (5 papers). The work is most often cited by research in Hematology (477 citations), Oncology (238 citations), Cancer Research (120 citations), Genetics (77 citations) and Molecular Biology (436 citations). Anna Kalff has collaborated with scholars based in Australia, United States and New Zealand. Frequent co-authors include Andrew Spencer, Tiffany Khong, Sridurga Mithraprabhu, Annie Chow, Andrew Grigg, Jane S. Hocking, Hang Quach, Krystal Bergin, John Reynolds and Andre Marziali. Their work appears in journals such as Blood, British Journal of Haematology, Bone Marrow Transplantation, Leukemia and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.